NCT02243319

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

A Randomized, Open Label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904

Detailed description

Randomized, open-label, multiple dose , 3-treatment, 6-sequence, 3-period, crossover study, The purpose of this study is to investigate the pharmacokinetic drug interactions between HGP1201 and HGP0904

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	HGP1201
DRUG	HGP0904
DRUG	HGP0904 and HGP1201 co-administraion

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-12-01
• Completion: 2014-12-01
• First posted: 2014-09-17
• Last updated: 2016-10-20

Locations

1 site across 1 country: South Korea